Tarsus Pharmaceuticals to present 11 abstracts at American Academy of Optometry annual meeting
Bitget2026/09/29 12:31- Tarsus Pharmaceuticals to present 11 scientific abstracts at the American Academy of Optometry 2026 Annual Meeting, Sept. 30-Oct. 3, 2026.
- Sessions scheduled in Anaheim, California, including poster presentations on Oct. 1, 2026, 4:30-6:30 p.m. PDT.
- One paper presentation set for Oct. 2, 2026, 4:00-4:15 p.m. PDT.
- Program highlights real-world outcomes with XDEMVY (lotilaner ophthalmic solution) 0.25%, Demodex blepharitis, ocular rosacea.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japanese and South Korean stock markets open

Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.
Amid opposition to data centers, Musk doubles down: SpaceX (SPCX.US) plans to build a $24 billion computing center and gas power plant in Texas.
According to a public hearing notice published on the Starbase website, SpaceX plans to build, own, and operate a gas-fired power plant and a supercomputing facility at its company town in Starbase, Texas.